Franziska Wittmann
Overview
Explore the profile of Franziska Wittmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mutschlechner D, Tscharre M, Wittmann F, Kitzmantl D, Schloglhofer T, Wadowski P, et al.
Res Pract Thromb Haemost
. 2024 Oct;
8(6):102564.
PMID: 39391561
Background: Patients with left ventricular assist devices (LVADs) are treated with a potent antithrombotic regimen to prevent pump thrombosis and thromboembolism. High on-treatment residual platelet reactivity (HRPR) is associated with...
2.
Tscharre M, Wittmann F, Kitzmantl D, Schloglhofer T, Cichra P, Lee S, et al.
Thromb Haemost
. 2022 Nov;
123(3):336-346.
PMID: 36402132
Background: The ABO blood group system is linked to hemostasis via its relationship with von Willebrand factor (VWF) and factor VIII (FVIII). In the current study, we investigated the association...
3.
Maw M, Schloglhofer T, Marko C, Aigner P, Gross C, Widhalm G, et al.
Front Cardiovasc Med
. 2022 May;
9:888269.
PMID: 35548436
Background: Contemporary Left Ventricular Assist Devices (LVADs) mainly operate at a constant speed, only insufficiently adapting to changes in patient demand. Automatic physiological speed control promises tighter integration of the...
4.
Tscharre M, Wittmann F, Kitzmantl D, Lee S, Eichelberger B, Wadowski P, et al.
Pharmaceuticals (Basel)
. 2022 Apr;
15(4).
PMID: 35455481
Growth differentiation factor (GDF)-15 inhibits platelet activation, prevents thrombus formation, and has been linked to bleeding events. This was a prospective study including 51 left-ventricular assist device (LVAD) patients on...
5.
Schloglhofer T, Wittmann F, Paus R, Riebandt J, Schaefer A, Angleitner P, et al.
Life (Basel)
. 2022 Mar;
12(3).
PMID: 35330210
Right heart failure (RHF) is a severe complication after left ventricular assist device (LVAD) implantation. The aim of this study was to analyze the incidence, risk factors, and biomarkers for...
6.
Schloglhofer T, Aigner P, Migas M, Beitzke D, Dimitrov K, Wittmann F, et al.
Artif Organs
. 2022 Jan;
46(6):1149-1157.
PMID: 34978722
Background: A relation between the left ventricular assist device inflow cannula (IC) malposition and pump thrombus has been reported. This study aimed to investigate if the pump position, derived from...
7.
Wittmann F, Schloglhofer T, Riebandt J, Schaefer A, Wiedemann D, Tschernko E, et al.
Life (Basel)
. 2021 Sep;
11(9).
PMID: 34575071
Several risk scores and classifications are available to predict peri- and post-operative mortality of patients with end stage heart failure receiving Left Ventricular Assist Device (LVAD) therapy. Sarcopenia has been...
8.
Tscharre M, Wittmann F, Kitzmantl D, Lee S, Eichelberger B, Wadowski P, et al.
Platelets
. 2021 Mar;
33(2):249-256.
PMID: 33760697
Left-ventricular assist devices (LVADs) improve outcomes in end-stage heart failure patients. Two centrifugal-flow LVAD systems are currently approved, HeartMate 3 (HM3) and Medtronic/Heartware HVAD (HVAD). Clinical findings suggest differences in...
9.
Schloglhofer T, Zapusek L, Wiedemann D, Riebandt J, Wittmann F, Dimitrov K, et al.
ASAIO J
. 2020 Jun;
67(2):157-162.
PMID: 32501824
Anticoagulation therapy in patients using left ventricular assist device (LVAD) is essential to reduce hemocompatibility related adverse events (HRAEs). Vitamin K-antagonist dosage must be adapted and monitored by INR point-of-care...
10.
Riebandt J, Schloglhofer T, Moayedifar R, Wiedemann D, Wittmann F, Angleitner P, et al.
ASAIO J
. 2020 May;
67(1):47-52.
PMID: 32404616
Despite increasing popularity and multiple postulated benefits, less invasive (LIS) left ventricular assist device (LVAD) implantation has not been sufficiently compared with standard full sternotomy (FS). We report the outcomes...